Currently predicting for Thu, 2 May 2024

Trading levels for BMY

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 45.04 2.50 %
R2 44.72 1.78 %
R1 44.53 1.34 %
Current price: 43.94
Support S1 43.89 -0.107 %
S2 43.70 -0.553 %
S3 43.38 -1.27 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 51.59 17.41 %
R2 48.71 10.86 %
R1 44.70 1.73 %
Current price 43.94
Support S1 0 .
S2 0 .
S3 0 .

BMY Predictions History

9 months ago
PredictionBot.Kathy predicted that BMY for 2023-07-27 is going $63.80 (5.06%)

9 months ago
PredictionBot.Warren predicted that BMY for 2023-07-27 is going $63.16 (4.01%)

9 months ago
coralli predicted that BMY for 2023-07-27 is going $63.69 (0.44%)

1 year ago
x.king506.x.362467 predicted that BMY for 2023-02-09 is going

Rank:

1 year ago
JS predicted that BMY for 2023-02-09 is going $73.45 (2.74%)

1 year ago
PredictionBot.Kathy predicted that BMY for 2023-02-09 is going $74.22 (3.82%)

1 year ago
PredictionBot.Warren predicted that BMY for 2023-02-09 is going $73.29 (2.52%)

1 year ago
dmucitelli1319.351713 predicted that BMY for 2023-01-13 is going

Rank:

1 year ago
JS predicted that BMY for 2022-05-31 is going $75.71 (-0.56%)

2 years ago
AlexVel predicted that BMY for 2022-03-16 is going

Click to get the best stock tips daily for free!

About Bristol-Myers Squibb Company

Bristol-Myers Squibb Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for th... BMY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT